Ultralife (ULBI) Invested Capital (2010 - 2026)

Ultralife has reported Invested Capital for 17 years, with the latest figure at $133.1 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 4.75% year-over-year to $133.1 million; the trailing twelve-month figure through Mar 2026 stood at $133.1 million (down 4.75% YoY), and the FY2025 full-year result was $134.3 million, down 1.96% from the prior year.
• Invested Capital for Q1 2026 stood at $133.1 million, down from $134.3 million in the prior quarter.
• The five-year high for Invested Capital was $142.1 million in Q2 2025, with the low at $117.3 million in Q3 2022.
• Average Invested Capital over 5 years is $129.2 million, with a median of $130.9 million recorded in 2024.
• Year-over-year, Invested Capital increased 11.23% in 2024 and dropped 4.75% in 2026.
• Tracing ULBI's Invested Capital over 5 years: stood at $118.3 million in 2022, then gained by 7.74% to $127.4 million in 2023, then advanced by 7.46% to $136.9 million in 2024, then slipped by 1.96% to $134.3 million in 2025, then decreased by 0.89% to $133.1 million in 2026.
• The last three Invested Capital figures came in at $133.1 million (Q1 2026), $134.3 million (Q4 2025), and $141.2 million (Q3 2025), per Business Quant data.

Peer Comparison